1996
DOI: 10.1177/000348949610500417
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Hypoplastic Maxillary Sinus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

1997
1997
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 2 publications
0
5
0
Order By: Relevance
“…Alterations of the craniofacial morphology during the evolution of the hominids was considered as an important factor affecting the maxillary sinus morphology (Proctor & Naclerio, 1996). Koppe & Nagai (1997) on the basis of their correlation analysis showed close relationships between the maxillary sinus volume and external cranial dimensions in the skulls of Japanese macaque while Koppe et al (2000) concluded that growth in the maxillary sinus size in the miniature pigs did not follow the growth pattern of skull.…”
Section: Discussionmentioning
confidence: 99%
“…Alterations of the craniofacial morphology during the evolution of the hominids was considered as an important factor affecting the maxillary sinus morphology (Proctor & Naclerio, 1996). Koppe & Nagai (1997) on the basis of their correlation analysis showed close relationships between the maxillary sinus volume and external cranial dimensions in the skulls of Japanese macaque while Koppe et al (2000) concluded that growth in the maxillary sinus size in the miniature pigs did not follow the growth pattern of skull.…”
Section: Discussionmentioning
confidence: 99%
“…Changes in craniofacial morphology observed during the evolution of Hominidae are an important factor that influences the maxillary sinus morphology [ 1 ]. The close relation between external cranial dimensions and maxillary sinus volume has been shown in Japanese macaque (Macaca fuscata) [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Theelieetiveness 01 ALLEGRAforthetreatmenl 01 seasonal allergierhini lis in patients 6 to 11years 01age Vl as demonstraled in one trial (n=411) in whieh ALLEGRA tablets 30 mg twice daily signilieanll y redueed total symptom seor es eompared to plaeebo, along Vlith ext rapolation 01 demonstraled eHieaey in pal ients ages 12yearsand above, and thepharmaeokinetiecomparisonsin adults and ehildren. Theelieeliveness 01 ALLEGRA lor the treatment 01ehronie idiopathi e urtiearia in palients 6…”
Section: Pediatrie Usementioning
confidence: 99%